Concepedia

Phase 1 study of ramucirumab (R) plus durvalumab (D) in patients (pts) with locally advanced and unresectable or metastatic gastrointestinal or thoracic malignancies (NCT02572687); Phase 1a results

C.-C. Lin, Talia Golan, J. Corral, Vicente Moreno, Hyun Cheol Chung, Heather Wasserstrom, Jing Yang, Gu Mi, Y. Bang

Annals of Oncology · 2016 · 10 citations · 0 references

Concepts

MedicineOncologyPharmacotherapyCancer PharmacologyOncology PharmacotherapyThoracic OncologyCancer ImmunotherapyImmunotherapy For Thoracic MalignanciesMalignant NeoplasmsMetastatic Disease TreatmentMetastatic Gastrointestinal CancerSystemic Therapy For Gastrointestinal CancersDurvalumab Consolidation TherapyDurvalumab Therapy